Citius extends employment agreement with EVP Holubiak and insider warrants to 2025

Citius Pharmaceuticals, Inc.

Myron Holubiak's employment term extended by one year to Oct 31, 2025; all other terms unchanged.
Investor warrants for 2,793,297 shares at $0.77 held by CEO Mazur and EVP Holubiak extended to Sept 27, 2025.
Underwriter warrants for 194,358 shares at $1.11875 extended to same date, held by Wainwright representatives.
Full exercise of all extended warrants would yield ~$2.4M in cash proceeds to the company.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.